# AH Equity Partners Bio II, L.L.C.

> Institutional holdings reported to the SEC as of Q3 2022 on Form 13F. CIK 1725722. Source: https://holderbook.com/funds/1725722-ah-equity-partners-bio-ii-l-l-c/

- Reported value: $143.5M
- Positions: 4
- Weight of the ten largest: 100.0%
- Filed: 2022-11-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| EQRX INC | [EQRX](https://holderbook.com/stocks/EQRX/) | $86.3M | 17,438,465 | 60.1% | 4 |
| NAUTILUS BIOTECHNOLOGY INC | [NAUT](https://holderbook.com/stocks/NAUT/) | $34.6M | 16,298,006 | 24.1% | 4 |
| ERASCA INC | [ERAS](https://holderbook.com/stocks/ERAS/) | $19.5M | 2,500,000 | 13.6% | 4 |
| INVITAE CORP | [NVTAQ](https://holderbook.com/stocks/NVTAQ/) | $3.1M | 1,276,541 | 2.2% | 4 |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q3 2022 | $143.5M | 4 |
| Q2 2022 | $142.4M | 4 |
| Q1 2022 | $173.6M | 4 |
| Q4 2021 | $192.0M | 4 |